Skip to main content
. 2023 Jun 19;13:1182748. doi: 10.3389/fonc.2023.1182748

Figure 2.

Figure 2

Overall survival (OS; A) and duration of treatment (DOT; B) in patients treated with immunotherapy in combination with chemotherapy (chemo-IT) (n=58).